These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17301519)

  • 1. [Recent advance in treatment of childhood acute lymphoblastic leukemia].
    Watanabe A
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):150-5. PubMed ID: 17301519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment for a high-risk group for childhood acute lymphoblastic leukemia].
    Koizumi S
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1042-9. PubMed ID: 10431575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
    Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
    Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic implication of DNA contents on long-term outcome of childhood acute lymphoblastic leukemia].
    Tsurusawa M; Katano N; Aoyama M; Fujimoto T; Nishikawa K; Hatae Y; Miyake M; Kawakami K; Furuyama T; Iwai A; Horikoshi Y
    Rinsho Ketsueki; 1997 Jul; 38(7):561-5. PubMed ID: 9267157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myeloid leukemia].
    Tabuchi K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):156-61. PubMed ID: 17301520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia and survival in childhood acute lymphoblastic leukemia.
    Teuffel O; Stanulla M; Cario G; Ludwig WD; Rottgers S; Schafer BW; Zimmermann M; Schrappe M; Niggli FK
    Haematologica; 2008 Nov; 93(11):1652-7. PubMed ID: 18815194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
    Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
    J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for childhood acute lymphoblastic leukemia.
    Cassano WF; Eskenazi AE; Frantz CN
    Curr Opin Oncol; 1993 Jan; 5(1):42-52. PubMed ID: 8427893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the treatment of children with high risk acute lymphoblastic leukemia (ALL) treated with modified "NEW YORK" protocols between 1987 and 2002].
    Balwierz W; Moryl-Bujakowska A; Skoczeń S; Pawińska K; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Rokicka-Milewska R; Pawelec K; Sońta-Jakimczyk D; Łuszczyńska A; Tomaszewska R; Wysocki M; Styczyński J; Swiatkiewicz V
    Przegl Lek; 2003; 60 Suppl 5():13-6. PubMed ID: 14575002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
    Bajel A; George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Pediatr Blood Cancer; 2008 Nov; 51(5):621-5. PubMed ID: 18688848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in children with acute lymphoblastic leukemia. Part II: Multivariate analysis. Children's Cancer and Leukemia Study Group.
    Hiyoshi Y; Fujimoto T; Kuriya N; Otani Y; Mibu K; Yanai M; Sasaki K; Shingaki Y; Yokoyama T; Kadoya S
    Jpn J Clin Oncol; 1985 Mar; 15(1):13-23. PubMed ID: 3856695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute childhood leukemia].
    Fujimoto T
    Rinsho Ketsueki; 1989 Aug; 30(8):1171-4. PubMed ID: 2601027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.